AU2013204740A1 - Methods of treating cancer using angiogenin or an angiogenin agonist - Google Patents
Methods of treating cancer using angiogenin or an angiogenin agonistInfo
- Publication number
- AU2013204740A1 AU2013204740A1 AU2013204740A AU2013204740A AU2013204740A1 AU 2013204740 A1 AU2013204740 A1 AU 2013204740A1 AU 2013204740 A AU2013204740 A AU 2013204740A AU 2013204740 A AU2013204740 A AU 2013204740A AU 2013204740 A1 AU2013204740 A1 AU 2013204740A1
- Authority
- AU
- Australia
- Prior art keywords
- angiogenin
- methods
- treating cancer
- agonist
- angiogenin agonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102100022987 Angiogenin Human genes 0.000 title 2
- 108010072788 angiogenin Proteins 0.000 title 2
- 206010028980 Neoplasm Diseases 0.000 title 1
- 239000000556 agonist Substances 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
Priority Applications (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2013204740A AU2013204740C1 (en) | 2012-05-10 | 2013-04-12 | Methods of treating cancer using angiogenin or an angiogenin agonist |
| BR112014027967A BR112014027967A2 (en) | 2012-05-10 | 2013-05-10 | cancer treatment methods using angiogenin or an angiogenin agonist |
| JP2015510577A JP2015517471A (en) | 2012-05-10 | 2013-05-10 | Cancer treatment method |
| US14/399,852 US9839676B2 (en) | 2012-05-10 | 2013-05-10 | Methods of treating cancer using angiogenin or an angiogenin agonist |
| EP13787726.2A EP2846820A4 (en) | 2012-05-10 | 2013-05-10 | Methods of treating cancer using angiogenin or an angiogenin agonist |
| NZ631749A NZ631749A (en) | 2012-05-10 | 2013-05-10 | Methods of treating cancer using angiogenin or an angiogenin agonist |
| CN201380037180.4A CN104470533A (en) | 2012-05-10 | 2013-05-10 | Methods of treating cancer using angiogenin or an angiogenin agonist |
| CA2872850A CA2872850A1 (en) | 2012-05-10 | 2013-05-10 | Methods of treating cancer using angiogenin or an angiogenin agonist |
| RU2014149807A RU2014149807A (en) | 2012-05-10 | 2013-05-10 | WAYS OF TREATMENT OF MALIGNANT NEW FORMATIONS USING ANGIOGENIN OR AN ANGIOGENIN AGONIST |
| PCT/AU2013/000478 WO2013166555A1 (en) | 2012-05-10 | 2013-05-10 | Methods of treating cancer using angiogenin or an angiogenin agonist |
| JP2018023212A JP2018100288A (en) | 2012-05-10 | 2018-02-13 | Methods of treating cancer |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2012901918 | 2012-05-10 | ||
| AU2012901918A AU2012901918A0 (en) | 2012-05-10 | Methods for treating cancer | |
| AU2013204740A AU2013204740C1 (en) | 2012-05-10 | 2013-04-12 | Methods of treating cancer using angiogenin or an angiogenin agonist |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| AU2013204740A1 true AU2013204740A1 (en) | 2013-12-12 |
| AU2013204740B2 AU2013204740B2 (en) | 2015-04-23 |
| AU2013204740C1 AU2013204740C1 (en) | 2015-10-01 |
Family
ID=49549993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2013204740A Ceased AU2013204740C1 (en) | 2012-05-10 | 2013-04-12 | Methods of treating cancer using angiogenin or an angiogenin agonist |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9839676B2 (en) |
| EP (1) | EP2846820A4 (en) |
| JP (2) | JP2015517471A (en) |
| CN (1) | CN104470533A (en) |
| AU (1) | AU2013204740C1 (en) |
| BR (1) | BR112014027967A2 (en) |
| CA (1) | CA2872850A1 (en) |
| NZ (1) | NZ631749A (en) |
| RU (1) | RU2014149807A (en) |
| WO (1) | WO2013166555A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2303311B1 (en) | 2008-05-14 | 2018-08-01 | Agriculture Victoria Services Pty Ltd | Angiogenin for use in treating skeletal muscle disorders |
| AU2013204740C1 (en) | 2012-05-10 | 2015-10-01 | Agriculture Victoria Services Pty Ltd | Methods of treating cancer using angiogenin or an angiogenin agonist |
| EP3113776B1 (en) * | 2014-03-06 | 2021-01-13 | University of Southern California | Use of short term starvation regimen in combination with kinase inhibitors to enhance traditional chemo-drug efficacy and feasibility and reverse side effects of kinases in normal cells and tissues |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2623509B1 (en) | 1987-11-19 | 1990-04-20 | Centre Nat Rech Scient | 17 KD PROTEIN WITH ANGIOGENIC ACTION, METHOD FOR ISOLATING IT FROM MAMMALIAN MILK, THERAPEUTIC COMPOSITIONS CONTAINING SAME, METHOD FOR DETECTION AND / OR DOSAGE AND IMMUNOLOGICAL REAGENTS FOR DETECTION AND DOSAGE OF ANGIOGENINS OF MAMMALS, AND OF THEIR FRAGMENTS |
| CA2128111C (en) | 1992-01-15 | 1998-06-16 | Klaas Daniel Kussendrager | Process for isolating lactoferrin and lactoperoxidase from milk and milk products, and products obtained by such process |
| DE69433870T2 (en) | 1993-03-18 | 2005-06-30 | Cytimmune Sciences, Inc. | COMPOSITION AND METHOD OF REDUCING THE TOXICITY OF BIOLOGICAL ACTIVE FACTORS |
| JP3112637B2 (en) | 1994-09-30 | 2000-11-27 | 雪印乳業株式会社 | Bone strengthener |
| JP2974604B2 (en) | 1996-01-23 | 1999-11-10 | 雪印乳業株式会社 | Basic protein composition, basic peptide composition and use thereof |
| JP3929088B2 (en) | 1996-06-20 | 2007-06-13 | 雪印乳業株式会社 | Bone formation promoter and bone resorption inhibitor |
| RU2110066C1 (en) | 1996-12-27 | 1998-04-27 | Московский государственный университет прикладной биотехнологии | Method of quantitatively determining angiogenin in biological sample |
| NL1005677C2 (en) | 1997-03-27 | 1998-09-29 | Campina Melkunie Bv | Method for recovering growth factors, or a composition containing one or more growth factors, from milk or a derivative thereof. |
| KR100236977B1 (en) | 1997-11-01 | 2000-01-15 | 윤재승 | A fusion protein of hegf and human antiogenin, and process for preparing the same |
| EP1083896A4 (en) | 1998-05-11 | 2002-09-11 | Endowment For Res In Human Bio | Use of neomycin for treating angiogenesis-related diseases |
| AU782394B2 (en) | 1999-06-29 | 2005-07-21 | J. Alexander Marchosky | Compositions and methods for forming and strengthening bone |
| EP1217070A1 (en) | 2000-12-22 | 2002-06-26 | CellGenix Technologie Transfer GmbH | Selective cytotoxic fusion proteins |
| TWI329129B (en) | 2001-02-08 | 2010-08-21 | Wyeth Corp | Modified and stabilized gdf propeptides and uses thereof |
| RU2204262C2 (en) | 2001-07-06 | 2003-05-20 | Московский государственный университет прикладной биотехнологии | Method for preparing biologically active protein concentrate enriched with pancreatic ribonuclease a, angiogenin and lysozyme from dairy ultrafiltrate |
| CN1161467C (en) * | 2001-07-09 | 2004-08-11 | 中国人民解放军军事医学科学院生物工程研究所 | Fusion protein with anti-tumor effect and application of the protein |
| JP4291967B2 (en) | 2001-11-08 | 2009-07-08 | 雪印乳業株式会社 | Skin collagen production promoter |
| JP2005518195A (en) | 2001-11-27 | 2005-06-23 | ワシントン・ユニバーシティ | Therapeutic proteins and therapeutic methods |
| AR042545A1 (en) | 2002-12-20 | 2005-06-22 | Amgen Inc | BINDING AGENTS THAT INHIBIT MIOSTATINE |
| JP4698935B2 (en) | 2003-05-07 | 2011-06-08 | 雪印乳業株式会社 | Skin collagen production promoter |
| WO2004106491A2 (en) | 2003-05-22 | 2004-12-09 | The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Angiogenin-based hiv-1 therapies |
| US8114969B2 (en) | 2003-10-01 | 2012-02-14 | Isis Innovation, Ltd. | Immunotoxin derived from a recombinant human autoantibody and method of using thereof |
| JP2007509846A (en) | 2003-10-15 | 2007-04-19 | バイエル・ヘルスケア・アクチェンゲゼルシャフト | Tetrahydro-naphthalene and urea derivatives |
| US20050180957A1 (en) | 2004-01-16 | 2005-08-18 | Scharp David W. | Method of using fibrin-bound angiogenic factors to stimulate vascularization of transplant site of encapsulated cells |
| US8147561B2 (en) | 2004-02-26 | 2012-04-03 | Endosphere, Inc. | Methods and devices to curb appetite and/or reduce food intake |
| AU2005219441A1 (en) | 2004-03-02 | 2005-09-15 | Acceleron Pharma Inc. | ALK7 and myostatin inhibitors and uses thereof |
| CN101267828A (en) * | 2004-06-22 | 2008-09-17 | 普罗医药公司 | Compositions and methods for co-delivery of anticancer drugs, antiangiogenic drugs and polysaccharides |
| GB0425625D0 (en) | 2004-11-22 | 2004-12-22 | Royal College Of Surgeons Ie | Treatment of disease |
| US20060251739A1 (en) | 2005-05-04 | 2006-11-09 | National Yang-Ming University | Composition and method for treating autoimmune disease and mucosal disorder |
| US20090036369A1 (en) | 2005-07-26 | 2009-02-05 | Kirin Pharma Kabushiki Kaisha | Anti-tumor agents comprising r-spondins |
| WO2007023479A2 (en) | 2005-08-23 | 2007-03-01 | Royal College Of Surgeons In Ireland | Treatment of central nervous system injury |
| CN105001320A (en) | 2005-11-23 | 2015-10-28 | 阿塞勒隆制药公司 | Activin-ActRIIa antagonists and uses for promoting bone growth |
| CN104072611A (en) | 2005-12-21 | 2014-10-01 | 维文蒂阿生物公司 | Novel cancer-associated antigen |
| EP2046799B1 (en) | 2006-04-26 | 2017-07-19 | Genentech, Inc. | Phosphoinositide 3-kinase inhibitor compounds and pharmaceutical compositions containing them |
| US8021659B2 (en) | 2006-04-28 | 2011-09-20 | Naidu Lp | Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof |
| US20070275036A1 (en) | 2006-05-18 | 2007-11-29 | Celldyne Biopharma, Llc | Avian follistatin product |
| EP2049151A4 (en) | 2006-07-17 | 2010-03-24 | Quintessence Biosciences Inc | Methods and compositions for the treatment of cancer |
| CN101626693B (en) | 2006-11-10 | 2014-05-14 | 墨累古尔本合作有限公司 | Method for preparing angiogenin |
| US7601689B2 (en) | 2007-04-12 | 2009-10-13 | Naidu Lp | Angiogenin complexes (ANGex) and uses thereof |
| WO2009043437A2 (en) | 2007-09-11 | 2009-04-09 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
| AU2009246052A1 (en) | 2008-05-14 | 2009-11-19 | Agriculture Victoria Services Pty Ltd | Orally administrable dosage forms comprising angiogenin and uses thereof |
| AU2013204721B2 (en) | 2008-05-14 | 2016-08-18 | Agriculture Victoria Services Pty Ltd | Methods for treating cachexia |
| EP2303311B1 (en) | 2008-05-14 | 2018-08-01 | Agriculture Victoria Services Pty Ltd | Angiogenin for use in treating skeletal muscle disorders |
| BRPI0911957A2 (en) | 2008-05-14 | 2016-08-23 | Agriculture Victoria Serv Pty | angiogenin-enriched milk fractions |
| US20130243728A9 (en) | 2009-11-18 | 2013-09-19 | Agriculture Victoria Services Pty Ltd | Recombinant microorganisms |
| EP2501411A4 (en) | 2009-11-18 | 2013-07-03 | Murray Goulburn Coop Co Ltd | Methods for improving oral delivery |
| WO2011060489A1 (en) | 2009-11-18 | 2011-05-26 | Murray Goulburn Co-Operative Co. Limited | Transgenic non-human animals |
| WO2013051767A1 (en) | 2011-10-06 | 2013-04-11 | 중앙대학교 산학협력단 | Novel use of angiogenin |
| AU2013204740C1 (en) | 2012-05-10 | 2015-10-01 | Agriculture Victoria Services Pty Ltd | Methods of treating cancer using angiogenin or an angiogenin agonist |
-
2013
- 2013-04-12 AU AU2013204740A patent/AU2013204740C1/en not_active Ceased
- 2013-05-10 CN CN201380037180.4A patent/CN104470533A/en active Pending
- 2013-05-10 US US14/399,852 patent/US9839676B2/en not_active Expired - Fee Related
- 2013-05-10 CA CA2872850A patent/CA2872850A1/en not_active Abandoned
- 2013-05-10 WO PCT/AU2013/000478 patent/WO2013166555A1/en not_active Ceased
- 2013-05-10 NZ NZ631749A patent/NZ631749A/en not_active IP Right Cessation
- 2013-05-10 BR BR112014027967A patent/BR112014027967A2/en not_active IP Right Cessation
- 2013-05-10 RU RU2014149807A patent/RU2014149807A/en unknown
- 2013-05-10 JP JP2015510577A patent/JP2015517471A/en active Pending
- 2013-05-10 EP EP13787726.2A patent/EP2846820A4/en not_active Withdrawn
-
2018
- 2018-02-13 JP JP2018023212A patent/JP2018100288A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL288181A (en) | Methods of treating cancer | |
| EP3071209A4 (en) | Use of sting agonist as cancer treatment | |
| EP3060207A4 (en) | Methods and compositions for treating cancer | |
| EP3027192A4 (en) | Methods for the treatment of solid tumors | |
| IL237791A0 (en) | Method of treating cancer | |
| EP2964028A4 (en) | Compounds for treatment of cancer | |
| EP3057594A4 (en) | Method of treating cancer | |
| EP2968254A4 (en) | Methods of treating lung cancer | |
| EP3077049A4 (en) | Compositions and methods for treating vitiligo | |
| EP2895206A4 (en) | Method of treating cancer | |
| EP2988659A4 (en) | Improved methods of cancer detection | |
| EP2970419B8 (en) | Methods of treating colorectal cancer | |
| EP2965086A4 (en) | Methods of detecting prostate cancer | |
| EP3008212A4 (en) | Methods of treatment of cancer | |
| SG11201508878WA (en) | Methods of treating cancer | |
| EP3004395A4 (en) | Compositions and methods for treating cancer | |
| EP3052102A4 (en) | Compositions and methods for treating cancers | |
| EP3074040A4 (en) | Method of treating cancer | |
| EP3082841A4 (en) | Methods for treating an animal | |
| EP3057593A4 (en) | Treatment for pancreatic cancer | |
| EP3011013A4 (en) | Methods for treatment of ovarian cancer | |
| EP3252171B8 (en) | Methods of treating cancer | |
| EP2991650A4 (en) | Methods for the treatment of cancer | |
| AU2013204740A1 (en) | Methods of treating cancer using angiogenin or an angiogenin agonist | |
| EP2846820A4 (en) | Methods of treating cancer using angiogenin or an angiogenin agonist |